Marex Group Plc (MRX) Financial Statements

MRX Financial Data

EBITDA$0.00

Revenue (TTM)$1659.00

Gross Profit (TTM)$1659.00

Gross Margin—

Operating Margin19.76%

ROE0.00%

ROA0.00%

Debt/Equity15.33

Current Ratio1.09

FCF$654.40M

FCF Yield15.96%

Piotroski F-Score—

Rev/Share (TTM)$0.00

50-Day MA$46.69

200-Day MA$38.55

Shares Outstanding0.07B

MRX Computed Insights

FCF$654.40M

FCF Growth Rate7.76%

EPS Growth (CAGR)50.00%

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

MRX Financial Statements & Data

Marex Group Plc (MRX) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Marex Group Plc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $1659.00. Gross profit (TTM) is $1659.00. EBITDA is $0.00. Earnings per share (EPS) is $3.86. The P/E ratio is 13356822.68. Market capitalization is $4.10B.

Free cash flow (FCF) is $654.40M. FCF growth rate is 7.76%. EPS growth CAGR is 50.00%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 5 years from FY21 to FY25. Net income history spans 5 years. Free cash flow and capital expenditure data spans 5 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Marex Group Plc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.